Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use

Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to ventilator-associated pneumonia and other secondary infections observed in COVID-19 patients. The expected consequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kullar, Ravina, Johnson, Stuart, McFarland, Lynne V., Goldstein, Ellie J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070357/
https://www.ncbi.nlm.nih.gov/pubmed/33918619
http://dx.doi.org/10.3390/antibiotics10040408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070357/
https://www.ncbi.nlm.nih.gov/pubmed/33918619
http://dx.doi.org/10.3390/antibiotics10040408

Ejemplares similares